Nestle (NSRGY) Stock Forecast & Price Target

Nestle
Bull Case

Here are some ways that investors could benefit from investing in Nestlé:

• Nestlé is currently trading at $96.49, which is below its 50-day simple moving average of $101.10 and 200-day simple moving average of $100.65, suggesting the stock may be undervalued relative to its recent trend and offering a potential entry point for investors.
• The company is actively diversifying its portfolio by investing $393 million in Brazil to build a new infant formula plant, a strategic move that expands its presence in a high-growth market and strengthens its core nutrition business through 2028.
• Nestlé is leveraging artificial intelligence and nutritional science to develop new products tailored for users of GLP-1 weight-loss drugs, turning a potential threat into a business opportunity by catering to millions of consumers taking medicines like Ozempic and Wegovy.
• Short interest in the stock has declined significantly, dropping 35.2% in August to 137,858 shares, which indicates a reduction in bearish sentiment and suggests that investors are increasingly confident in the company's future performance.
• Erste Group Bank recently upgraded its rating on Nestlé to "Buy" and raised its FY2026 earnings per share estimate to $5.61, reflecting analyst confidence in the company's ability to deliver strong financial results and maintain its market position.